HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

301126

CNE1000054V3

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-07-04 EDT			5-day change	1st Jan Change
9.4 ^CNY	+2.62%		+4.10%	-27.86%

07-01	Tranche Update on Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's Equity Buyback Plan announced on June 5, 2024.	CI
06-05	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd commences an Equity Buyback for CNY 15 million worth of its shares, under the authorization approved on April 15, 2024.	CI

Tranche Update on Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's Equity Buyback Plan announced on June 5, 2024.

July 01, 2024 at 04:42 am

From June 4, 2024 to June 30, 2024, the company has repurchased 427,500 shares, representing 0.21% for CNY 4 million. With this, the company has completed the repurchase of 427,500 shares, representing 0.21% for CNY 4 million under the buyback announced on June 5, 2024.

Latest news about Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Tranche Update on Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's Equity Buyback Plan announced on June 5, 2024.	07-01	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd commences an Equity Buyback for CNY 15 million worth of its shares, under the authorization approved on April 15, 2024.	06-05	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	05-21	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Cash Dividend for 2023	05-15	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding	03-27	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Board Elections	23-10-11	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed the share acquisition agreement to acquire 51% stake in Shanxi Simaile Pharmaceutical Chain Co., Ltd. from Yang Jinjiang, Liu Hongming for approximately CNY 330 million.	23-09-18	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire Yinchuan Meihetai Pharmaceutical Chain Co., Ltd. from Xie Huiyang and Xie Xiaolong for approximately CNY 250 million.	23-07-03	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 12, 2023	23-06-02	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Final Cash Dividend for 2022	23-05-15	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd cancelled the transaction announced on May 18, 2022	23-04-27	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 300 million in funding	23-04-27	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Proposes Final Cash Dividend for the Year 2022	23-04-24	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
Hunan Tongjian Pharmacy to Buy 86% Stake in Local Peer For 341 Million Yuan	23-01-03	MT
Hunan Tongjian Pharma to Buy 86% of Local TCM Maker For 341 Million Yuan	22-12-22	MT
Certain A Shares of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.	22-12-07	CI
Hunan Dajiaweikang Pharma to Buy 85.7% Stake in Pharma Firm	22-11-16	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed a Share Transfer Agreement to acquire a 85.7143% stake in Hunan Tianjicaotang Pharmaceutical CO.,LTD. from Weng Xiaotao and Xiang Zhongyou for CNY 340 million.	22-11-15	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd completed the acquisition of 51% stake in Ningxia Delixin Medicine Co., Ltd. from Duan Junzhang, Duan Xisheng and Zhao Xupeng.	22-08-09	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-29	CI

Chart Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Duration

Period

Chart Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

More charts

Company Profile

Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is a China-based company mainly engaged in the distribution and retail business of drugs, biological products, medical devices and other products. The Company is also engaged in reproductive hospital business. The pharmaceutical distribution business includes pure sales mode and allocation mode, mainly engaged in anti-tumor drugs, immunomodulatory drugs, cardiovascular and cerebrovascular drugs, respiratory drugs, antiviral drugs and other new and special drugs. The pharmaceutical retail business is mainly engaged in professional pharmacies, focusing on the sales of prescription drugs, mainly including Special Service pharmacy business and direct to patient (DTP) pharmacy business. The reproductive hospital business is mainly engaged in the diagnosis and treatment of gynecological and urological diseases.

Sector

Pharmaceuticals

Calendar

2024-08-29 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD	-27.86%	267M
MCKESSON CORPORATION	+26.95%	76.24B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+15.06%	8.76B
SINOPHARM GROUP CO. LTD.	0.00%	8.17B
HUADONG MEDICINE CO., LTD	-33.62%	6.63B
H. LUNDBECK A/S	+20.45%	5.53B
GALENICA AG	+2.13%	4.13B
EBOS GROUP LIMITED	-9.75%	3.8B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-9.46%	3.32B
MEDIPAL HOLDINGS CORPORATION	+7.77%	3.2B